Retinopathy of Prematurity: Evolving Treatment With Anti–Vascular Endothelial Growth Factor
Purpose To discuss the evolution in retinopathy of prematurity since its first description as retrolental fibroplasia in the United States, including the changes in the understanding of pathophysiology; methods of…